TY - JOUR
T1 - HIV care and treatment of American Indians/Alaska natives with diagnosed HIV infection – 27 states and the District of Columbia, 2012
AU - Mitsch, Andrew
AU - Surendera Babu, Aruna
AU - Seneca, Dean
AU - Whiteside, Y. Omar
AU - Warne, Donald
N1 - Publisher Copyright:
© 2016, © The Author(s) 2016.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017/9/1
Y1 - 2017/9/1
N2 - The objective of this study was to measure linkage to care, retention in care, and suppressed viral load (VL) among American Indians/Alaska Natives (AIs/ANs) aged ≥13 years with diagnosed HIV infection. We used national HIV case surveillance data to measure linkage to care, defined as ≥1 CD4 or VL test ≤1 month after HIV diagnosis during 2013; retention in care, defined as ≥2 CD4 or VL tests ≥3 months apart during 2012; and suppressed VL, defined as <200 copies/mL at the most recent VL test during 2012. In 2013, 74.1% of AIs/ANs were linked to care. At year-end 2012, 46.9% of AIs/ANs were retained in care and 45.1% were virally suppressed. A lower percentage of females (41.3%), compared with males (46.5), were virally suppressed. By age group, the lowest percentage of virally suppressed AIs/ANs (37.5%) were aged 13–34 years. To improve individual health and to prevent HIV among AIs/ANs, outcomes must improve – particularly for female AIs/ANs and for AIs/ANs aged 13–34 years. Screening for HIV infection in accordance with Centers for Disease Control and Prevention’s testing recommendations can lead to improvements along the continuum of HIV care.
AB - The objective of this study was to measure linkage to care, retention in care, and suppressed viral load (VL) among American Indians/Alaska Natives (AIs/ANs) aged ≥13 years with diagnosed HIV infection. We used national HIV case surveillance data to measure linkage to care, defined as ≥1 CD4 or VL test ≤1 month after HIV diagnosis during 2013; retention in care, defined as ≥2 CD4 or VL tests ≥3 months apart during 2012; and suppressed VL, defined as <200 copies/mL at the most recent VL test during 2012. In 2013, 74.1% of AIs/ANs were linked to care. At year-end 2012, 46.9% of AIs/ANs were retained in care and 45.1% were virally suppressed. A lower percentage of females (41.3%), compared with males (46.5), were virally suppressed. By age group, the lowest percentage of virally suppressed AIs/ANs (37.5%) were aged 13–34 years. To improve individual health and to prevent HIV among AIs/ANs, outcomes must improve – particularly for female AIs/ANs and for AIs/ANs aged 13–34 years. Screening for HIV infection in accordance with Centers for Disease Control and Prevention’s testing recommendations can lead to improvements along the continuum of HIV care.
KW - Epidemiology
KW - HIV
KW - North America
KW - highly active antiretroviral therapy
KW - prevention
UR - http://www.scopus.com/inward/record.url?scp=85026729810&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026729810&partnerID=8YFLogxK
U2 - 10.1177/0956462416681183
DO - 10.1177/0956462416681183
M3 - Article
C2 - 27872322
AN - SCOPUS:85026729810
SN - 0956-4624
VL - 28
SP - 953
EP - 961
JO - International Journal of STD and AIDS
JF - International Journal of STD and AIDS
IS - 10
ER -